Electroneum (ETN) has today completed an unprecedented fork of it’s blockchain, bringing a host of game-changing advancements that will unlock an extremely exciting second half to this year. Immediate benefits,..
Oxford BioMedica (OXB) is a specialist, advanced therapy, viral-vector biopharma company. It offers vector manufacturing and development services, while developing proprietary drug candidates, with its LentiVector® platform. 2018 saw significant..
The Unite Group plc (LON: UTG), the UK’s leading manager and developer of student accommodation, announced today the quarterly property valuation of the Unite UK Student Accommodation Fund (‘USAF’) and..
“I am pleased to announce that Acacia achieved a 51% increase in production in the second quarter of 2019 compared to Q1 2019, following the successful implementation of our revised..
Imperial Brands PLC (LON:IMB) today announced a revised capital allocation and shareholder distributions policy to support continued growth and optimised returns for shareholders. The Board reaffirms the 10% dividend growth..
Ferguson plc (LON: FERG) announced today that, in continuation of the share repurchase programme announced by the Company on 11 June 2019, it has instructed its broker J.P. Morgan Securities..
Further to the theft of customer data from British Airways’ website, disclosed on 6 September 2018 and 25 October 2018, British Airways has been notified by the UK Information Commissioner’s..
AVEVA Group plc (LON:AVV), a global leader in engineering and industrial software, will be holding its Annual General Meeting today at 9.30 a.m. AVEVA will not be providing a trading..
Versarien plc (LON: VRS), the advanced materials engineering group, has today announced that the Company has secured its first graphene orders from the North American corporate research and development centre..
appScatter Group plc (LON: APPS), the app management and data intelligence platform, has today announced that it has signed a Joint Venture Agreement with interarrows Inc., the Tokyo based on-demand..
4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, has today announced an update on its lead Live Biotherapeutic candidate for asthma, MRx-4DP0004. A multicentre..
